Ferran Bolao

L'hospitalet De Llobregat, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder.

Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder.

Journal: Alcohol, clinical & experimental research

Published: December 29, 2023

Author Correction: Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder.

Author Correction: Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder.

Journal: Scientific reports

Published: March 15, 2023

Fungal plasma biomarkers in patients admitted for inpatient treatment of alcohol use disorder.

Fungal plasma biomarkers in patients admitted for inpatient treatment of alcohol use disorder.

Journal: Alcohol, clinical & experimental research

Published: January 02, 2023

Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder.

Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder.

Journal: Drug and alcohol dependence

Published: October 04, 2022

Prevalence and associations of metabolic syndrome in patients with alcohol use disorder.

Prevalence and associations of metabolic syndrome in patients with alcohol use disorder.

Journal: Scientific reports

Published: July 24, 2021

Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder.

Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder.

Journal: Journal of clinical medicine

Published: June 19, 2021

Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use.

Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use.

Journal: World journal of gastroenterology

Published: February 09, 2021

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness.

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 29, 2020

Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder.

Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder.

Journal: Journal of addiction medicine

Published: August 10, 2020

Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder.

Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder.

Journal: Scientific reports

Published: July 06, 2020

Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment.

Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment.

Journal: Drug and alcohol dependence

Published: March 12, 2020

Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment.

Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment.

Journal: Alcoholism, clinical and experimental research

Published: April 10, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026